Bio-Connect
Immunohistochemical analysis of paraffin-embedded U373 xenograft, using GBP5(GTX118635) antibody at 1:500 dilution. Antigen Retrieval: Trilogy? (EDTA based, pH 8.0) buffer, 15min
Immunohistochemical analysis of paraffin-embedded U373 xenograft, using GBP5(GTX118635) antibody at 1:500 dilution.
 Antigen Retrieval: Trilogy? (EDTA based, pH 8.0) buffer, 15min
Immunohistochemical analysis of paraffin-embedded U373 xenograft, using GBP5(GTX118635) antibody at 1:500 dilution. Antigen Retrieval: Trilogy? (EDTA based, pH 8.0) buffer, 15min

GBP5 antibody [N3C3]

GTX118635
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetGBP5
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    GBP5 antibody [N3C3]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.66 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID115362
  • Target name
    GBP5
  • Target description
    guanylate binding protein 5
  • Target synonyms
    GBP-5, guanylate-binding protein 5, GBP-TA antigen, GTP-binding protein 5, guanine nucleotide-binding protein 5
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ96PP8
  • Protein Name
    Guanylate-binding protein 5
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Cheng SW, Chen PC, Lin MH, et al. GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer. Biomedicines. 2021,9(4). doi: 10.3390/biomedicines9040371
    Read this paper
  • Cheng SW, Chen PC, Ger TR, et al. GBP5 Serves as a Potential Marker to Predict a Favorable Response in Triple-Negative Breast Cancer Patients Receiving a Taxane-Based Chemotherapy. J Pers Med. 2021,11(3). doi: 10.3390/jpm11030197
    Read this paper